Sana Biotechnology
SANA
SANA
154 hedge funds and large institutions have $398M invested in Sana Biotechnology in 2025 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 49 increasing their positions, 47 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1.8% less ownership
Funds ownership: 66.32% → 64.52% (-1.8%)
4% less funds holding
Funds holding: 160 → 154 (-6)
17% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 30
Holders
154
Holding in Top 10
3
Calls
$1.74M
Puts
$952K
Top Buyers
| 1 | +$1.7M | |
| 2 | +$1.62M | |
| 3 | +$1.45M | |
| 4 |
Morgan Stanley
New York
|
+$1.35M |
| 5 |
Millennium Management
New York
|
+$1.16M |
Top Sellers
| 1 | -$9.15M | |
| 2 | -$5.43M | |
| 3 | -$1.24M | |
| 4 |
IHAM
Integral Health Asset Management
New York
|
-$1.03M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$923K |